Search Orphan Drug Designations and Approvals
-
Generic Name: | Sodium phenylacetate/sodium benzoate 10%/10% Injection |
---|---|
Date Designated: | 06/03/2005 |
Orphan Designation: | Treatment of grade III and IV hepatic encephalopathy |
Orphan Designation Status: | Designated |
FDA Orphan Approval Status: | Not FDA Approved for Orphan Indication |
Sponsor: |
Ucyclyd Pharma, Inc. 7720 N. Dobson Road Scottsdale, Alaska 85256 United States The sponsor address listed is the last reported by the sponsor to OOPD. |
*Data for the Date Designation Withdrawn or Revoked field are shown for designations withdrawn or revoked after 08/12/2013.
-